STONKWHISPER
← Back to Intel
Insider ActivityELVN

Collins Helen Louise, CHIEF MEDICAL OFFICER at Enliven Therapeutics, Inc., sold $52K of ELVN

Updated Jun 8, 2026
Collins Helen Louise CHIEF MEDICAL OFFICER
Enliven Therapeutics, Inc. · $ELVN
$52K Total Value
1,302 Shares Traded
$40.2473 Price / Share
25,223 Shares Owned After
2026-05-20 Filing Date

Transaction Details

InsiderCollins Helen Louise
TitleCHIEF MEDICAL OFFICER
CompanyEnliven Therapeutics, Inc.
TickerELVN
Transaction TypeSale
Transaction Date2026-05-18
Shares Traded1,302
Price Per Share$40.2473
Total Value$52K
Filed Date2026-05-20
Accession Number0001701247-26-000007

Ownership Context

Shares Owned After Transaction25,223
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001701247-26-000007

Other Insider Trades — ELVN

Other Trades by Collins Helen Louise

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for ELVN — Enliven Therapeutics, Inc. →

Whisper Score — ELVN

50.0
Active Discussion
Current Whisper Score

See full analysis for ELVN →

Track ELVN insider activity in real time on The Wire →

Get alerts when Collins Helen Louise files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 08, 2026 at 07:05 UTC

Want real-time data? Access The Wire for live sentiment tracking.